Homeopathy for Prevention of Atrial Fibrillation After Aortocoronary Bypass Surgery
NCT ID: NCT00861237
Last Updated: 2018-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
12 participants
INTERVENTIONAL
2008-07-31
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Atrial Fibrillation Registry 2017
NCT05023590
Vernakalant Versus Flecainide: Atrial Contractility
NCT01646281
Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation
NCT02839304
Efficacy of Different Ablation Strategies for Controlling Atrial Fibrillation
NCT00379301
Noninvasive Mapping Before Surgical Ablation
NCT06803615
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo globules group
Patients receive Placebo globules made out of sugar and looking similar to active drug sublingually before surgery.
Placebo (placebo comparator)
Patients receive Placebo looking similar to active drug
Nux vomica group
Patients receive Nux vomica globules made out of sugar sublingually before surgery.
Nux vomica (active comparator)
Patients receive Nux vomica in a homeopathic potentiation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nux vomica (active comparator)
Patients receive Nux vomica in a homeopathic potentiation
Placebo (placebo comparator)
Patients receive Placebo looking similar to active drug
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with preoperative atrial fibrillation and/or hyperthyreosis
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Frass
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Frass, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Vienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept Surgery, Med Univ Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2342
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.